Journal Article

Efficacy of crushed lanthanum carbonate for hyperphosphatemia in hemodialysis patients undergoing tube feeding

Yukie Kitajima, Taeko Takahashi, Yuzuru Sato and Yutaka Nakaya

in Clinical Kidney Journal

Published on behalf of European Renal Association - European Dialysis and Transplant Assoc

Volume 4, issue 4, pages 253-255
Published in print August 2011 | ISSN: 1753-0784
Published online April 2011 | e-ISSN: 1753-0792 | DOI: https://dx.doi.org/10.1093/ndtplus/sfr034
Efficacy of crushed lanthanum carbonate for hyperphosphatemia in hemodialysis patients undergoing tube feeding

Show Summary Details

Preview

Lanthanum carbonate (LaC) is a non-calcium-based phosphate binder used to treat hyperphosphatemia in patients with chronic kidney disease. Oral administration of LaC is difficult in patients undergoing tube feeding or those who are of advanced age because it is essential to chew the LaC tablet sufficiently before swallowing it. We report two cases in whom crushed LaC was used in hemodialysis patients undergoing tube feeding. In both cases, previously crushed LaC was mixed into enteral nutrients. We found that LaC administered this way was effective for decreasing serum phosphorus levels.

Keywords: hyperphosphatemia; lanthanum carbonate; phosphate binder

Journal Article.  1195 words.  Illustrated.

Subjects: Nephrology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content. subscribe or login to access all content.